Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Scherer

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediatorsGeertje J D van Mierlo, Hans U Scherer, Marjolijn Hameetman, et al.
Annals of the Rheumatic Diseases|April 30, 2013
Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritisPriscilla F Kerkman, Yoann Rombouts, Ellen I H van der Voort, et al.
Journal of Autoimmunity|September 29, 2024
Autoreactive B cells remain active despite clinical disease control in rheumatoid arthritisSam Neppelenbroek, Nienke J Blomberg, Arieke S B Kampstra, et al.
Annals of the Rheumatic Diseases|April 13, 2016
Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodiesPriscilla F Kerkman, Ayla C Kempers, Ellen I H van der Voort, et al.
Annals of the Rheumatic Diseases|November 12, 2010
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label studyM O Becker, C Brückner, H U Scherer, et al.
Seminars in Arthritis and Rheumatism|November 20, 2022
Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesisSophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, et al.
Frontiers in Immunology|October 2, 2019
<i>N</i>-Glycosylation Site Analysis of Citrullinated Antigen-Specific B-Cell Receptors Indicates Alternative Selection Pathways During Autoreactive B-Cell DevelopmentRochelle D Vergroesen, Linda M Slot, Barbera D C van Schaik, et al.
The Journal of Rheumatology|June 3, 2020
Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic SclerosisNina M van Leeuwen, Corrie M Wortel, Cynthia M Fehres, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivitiesAndreea Ioan-Facsinay, Hanane el-Bannoudi, Hans U Scherer, et al.
NAR Genomics and Bioinformatics|July 20, 2022
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq dataTommaso Andreani, Linda M Slot, Samuel Gabillard, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediatorsGeertje J D van Mierlo, Hans U Scherer, Marjolijn Hameetman, et al.
Annals of the Rheumatic Diseases|April 30, 2013
Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritisPriscilla F Kerkman, Yoann Rombouts, Ellen I H van der Voort, et al.
Journal of Autoimmunity|September 29, 2024
Autoreactive B cells remain active despite clinical disease control in rheumatoid arthritisSam Neppelenbroek, Nienke J Blomberg, Arieke S B Kampstra, et al.
Annals of the Rheumatic Diseases|April 13, 2016
Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodiesPriscilla F Kerkman, Ayla C Kempers, Ellen I H van der Voort, et al.
Annals of the Rheumatic Diseases|November 12, 2010
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label studyM O Becker, C Brückner, H U Scherer, et al.
Seminars in Arthritis and Rheumatism|November 20, 2022
Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesisSophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, et al.
Frontiers in Immunology|October 2, 2019
<i>N</i>-Glycosylation Site Analysis of Citrullinated Antigen-Specific B-Cell Receptors Indicates Alternative Selection Pathways During Autoreactive B-Cell DevelopmentRochelle D Vergroesen, Linda M Slot, Barbera D C van Schaik, et al.
The Journal of Rheumatology|June 3, 2020
Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic SclerosisNina M van Leeuwen, Corrie M Wortel, Cynthia M Fehres, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivitiesAndreea Ioan-Facsinay, Hanane el-Bannoudi, Hans U Scherer, et al.
NAR Genomics and Bioinformatics|July 20, 2022
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq dataTommaso Andreani, Linda M Slot, Samuel Gabillard, et al.
Pageof 13